Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	363
Overall Study	STARTED	BG00012 240 mg Twice Daily (BID)	359
Overall Study	STARTED	BG00012 240 mg 3 Times Daily (TID)	345
Overall Study	STARTED	Glatiramer Acetate (GA) 20 mg Injection Once Daily (QD)	350
Overall Study	COMPLETED	Placebo	278
Overall Study	COMPLETED	BG00012 240 mg Twice Daily (BID)	284
Overall Study	COMPLETED	BG00012 240 mg 3 Times Daily (TID)	273
Overall Study	COMPLETED	Glatiramer Acetate (GA) 20 mg Injection Once Daily (QD)	292
Overall Study	NOT COMPLETED	Placebo	85
Overall Study	NOT COMPLETED	BG00012 240 mg Twice Daily (BID)	75
Overall Study	NOT COMPLETED	BG00012 240 mg 3 Times Daily (TID)	72
Overall Study	NOT COMPLETED	Glatiramer Acetate (GA) 20 mg Injection Once Daily (QD)	58

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00451451/flow